skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5i - even with all the problems at Valeant, it looks like it has a higher PE than CXR? For an investor willing to accept risk, is staying in CXR a decent decision? Im looking at the revised guidance and earnings and even with the lower expectations, it is expected to make big earnings and seems to be a very cheap stock. Thanks, Neil
Read Answer Asked by Neil on August 17, 2016
Q: I enjoy your reply to our questions very much and feel time to have your option about my holding for VRX ,CXR and AGN.specially about VRX which I have 700 shares. My healthcare mutual fund seems not performance very well. Should I hold ,sale or buy more?Thanks
Read Answer Asked by qing jie on June 07, 2016
Q: Not a question, but a comment, further to Valeant pharmaceuticals. Aren't they the company that bought up off patent drugs and then boosted the cost by a couple thousand percent, thus by passing the cost of R &D, but still charging the exorbitant prices they claim are necessary to make back R &D? I'm stunned nothing seems to have been done about this.
Read Answer Asked by M.S. on May 03, 2016
Q: Valeant was a company showing everyone that is was not a well run company with no R&D, and a CEO focused only on expansion and looking good to the stock market. And funny accounting.

But the market, Wall Street, Bay Street and most investors willing overlooked it!! Including 5iResearch.

Podcast: As identified from minutes 0:35:10 to 0:45:10

http://www.podbean.com/media/share/dir-4scbv-17fda94
Read Answer Asked by Stan (1) on May 02, 2016
Q: Hi Peter, So tomorrow probably would be a significant down day as this futile attempt by this credit holder to ask for default. Can you give me reasons why some rational investor should not buy(as company already promised filing by April 30th)? I see these positive short term catalysts. 1. 10-K file by 30th April, 2. New CEO in weeks, 3. Probably some analyst upgrade days after 10-K filing, 4. 2nd quarter report showing nice cash flow. On the negative I see 1. Hilary Clinton's posturing and other headline risks. Can you please think of any other negative catalysts I am missing? Your detail analysis please.

Also is there an opportunity in Valeant bonds? Can you please provide some tickers of their bonds(probably those are maturing after 2018) from your Bloomberg? I could not find it. And your detail analysis on their bonds please. Much appreciated.
Read Answer Asked by Sridip on April 13, 2016
Q: VRX shares have certainly been my most profitable trades since the fall of 2015 with continuing Short positions, however I have a small amount left as of today - April 1. The remaining holdings are through TSX but held in an Ontario corporation. Based on the 15 day Stop Trading Order by the Quebec authority starting today, what is your advise? Thank you.
Read Answer Asked by Robert on April 01, 2016
Q: Hi Peter, How do you analyze the current situation? I heard on CNBC that it is not in debt holder's interest to serve them default notice as then debt will go down more in short term. What else is unknown? If we all agree with the guidance it is 2.5X 2016 earnings now. Do they have to issue any new debt? If not then there is no question of their borrowing rate going up. Am I right? So how does this temporary situation have any real business implications? You can figure out from my tone that I am long on this name. Now here is my reason for being long. 1. Every day 10000 people in north america turning 60 until 2030, so they got tailwind for derma and GI. 2. Also they have diversified across eastern Europe and mexico, so again well diversified. 3. US congress and senate still held by republicans, so even Hillary/Sanders cannot pass anything to curb drug prices in 2017-2018. 4.They have 3 very successful activist(2 valueAct, 1 pershing) on their board, who will extract value, also I hope they did/still doing extensive due diligence. 5. Debt- it is not mining or oil, they will have strong cash flow around $2 billion to pay the debt. Anyways, can you please come up with some points that a guy with short position will think at this price point?? Also please correct me if I am wrong in my long assumptions. I would better be wrong than loose money.
Read Answer Asked by Sridip on March 18, 2016
Q: Hi Peter, I listened 2 hours conference call yesterday and went through the presentation and it seems like to me that their 2016 estimate is lowered because of some headwinds and also some because they want to be conservatives on their estimate. Did you feel the same from their call? Also I don't understand why could not they file 10-K before March 15? Cannot they ask their board committee to work extra hours for review? Or cannot they pay more to PWC to audit it faster? I don't understand the reason? With their lower earnings estimate it seems like they have 3 times 2016 earnings now? Do you think it is a contrarian buy now? What else can be other negative catalyst to take it more down from here? would you suggest to buy for 3 years hold?
Read Answer Asked by Sridip on March 17, 2016
Q: Just sell - NOW!! Don't wait another day! JUST SELL!!!
With 30B in debt; nearly 40B in questionable Goodwill & In-tangible Assets & no audited Financial Statements; - what else would you need. As well, apparently they are now in breach of their Walmart contract for non-compliance & of course, there is the US Justice Dept. investigation as well as the SEC probe. Sounds about right for an auction - if there will be any realizable assets.
Read Answer Asked by Robert on March 16, 2016